Literature DB >> 16291813

Most visits of most patients with rheumatoid arthritis to most rheumatologists do not include a formal quantitative joint count.

T Pincus1, O G Segurado.   

Abstract

OBJECTIVE: To ask rheumatologists about the likelihood of performing a formal joint count at each visit of a patient with rheumatoid arthritis (RA) in standard clinical care.
METHOD: Direct query of rheumatologists at an international meeting of about 600 rheumatologists from 17 European countries.
RESULTS: Overall, 14% of rheumatologists reported performing a formal joint count at each visit of each patient, and 44% of rheumatologists reported performing a formal joint count at more than 50% of visits of patients with RA. Therefore, 56% of rheumatologists reported performing a joint count at fewer than 50% of visits, including 45% at fewer than 25% of visits. One in eight rheumatologists (13%) reported never performing a formal joint count.
CONCLUSION: Although the joint count remains the most specific measure for RA, most visits of most patients with RA to most rheumatologists do not include a formal quantitative joint count.

Entities:  

Mesh:

Year:  2005        PMID: 16291813      PMCID: PMC1798189          DOI: 10.1136/ard.2005.044230

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  15 in total

1.  Joint counts in routine practice.

Authors:  D L Scott; C Antoni; E H Choy; P C L M Van Riel
Journal:  Rheumatology (Oxford)       Date:  2003-03-31       Impact factor: 7.580

2.  The assessment of rheumatoid arthritis and the acceptability of self-report questionnaires in clinical practice.

Authors:  Frederick Wolfe; Theodore Pincus; Ann K Thompson; Joseph Doyle
Journal:  Arthritis Rheum       Date:  2003-02-15

3.  A simplified twenty-eight-joint quantitative articular index in rheumatoid arthritis.

Authors:  H A Fuchs; R H Brooks; L F Callahan; T Pincus
Journal:  Arthritis Rheum       Date:  1989-05

4.  Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.

Authors:  D M Ritchie; J A Boyle; J M McInnes; M K Jasani; T G Dalakos; P Grieveson; W W Buchanan
Journal:  Q J Med       Date:  1968-07

5.  American Rheumatism Association nomenclature and classification of arthritis and rheumatism (1983).

Authors:  J L Decker
Journal:  Arthritis Rheum       Date:  1983-08

6.  Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group.

Authors:  P Tugwell; G Wells; V Strand; A Maetzel; C Bombardier; B Crawford; C Dorrier; A Thompson
Journal:  Arthritis Rheum       Date:  2000-03

7.  An experiment in reducing interobserver variability of the examination for joint tenderness.

Authors:  A V Klinkhoff; N Bellamy; C Bombardier; S Carette; A Chalmers; J M Esdaile; C Goldsmith; P Tugwell; H A Smythe; W W Buchanan
Journal:  J Rheumatol       Date:  1988-03       Impact factor: 4.666

8.  Erosions develop rarely in joints without clinically detectable inflammation in patients with early rheumatoid arthritis.

Authors:  Tuulikki Sokka; Hannu Kautiainen; Timo Möttönen; Pekka Hannonen
Journal:  J Rheumatol       Date:  2003-12       Impact factor: 4.666

9.  An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial.

Authors:  T Pincus; V Strand; G Koch; I Amara; B Crawford; F Wolfe; S Cohen; D Felson
Journal:  Arthritis Rheum       Date:  2003-03

10.  The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials.

Authors:  D T Felson; J J Anderson; M Boers; C Bombardier; M Chernoff; B Fried; D Furst; C Goldsmith; S Kieszak; R Lightfoot
Journal:  Arthritis Rheum       Date:  1993-06
View more
  14 in total

Review 1.  [Activity-score based therapy in rheumatoid arthritis].

Authors:  K Machold; V Nell; D Aletaha; J Smolen; T Stamm
Journal:  Z Rheumatol       Date:  2006-03       Impact factor: 1.372

2.  Declines in number of tender and swollen joints in patients with rheumatoid arthritis seen in standard care in 1985 versus 2001: possible considerations for revision of inclusion criteria for clinical trials.

Authors:  T Pincus; T Sokka; C P Chung; G Cawkwell
Journal:  Ann Rheum Dis       Date:  2005-12-08       Impact factor: 19.103

3.  Evaluation of disease activity in rheumatoid arthritis by Routine Assessment of Patient Index Data 3 (RAPID3) and its correlation to Disease Activity Score 28 (DAS28) and Clinical Disease Activity Index (CDAI): an Indian experience.

Authors:  H Singh; V Gupta; S Ray; H Kumar; P Talapatra; M Kaur; S Kumar; S Arya; R Mathur; N Ghangas
Journal:  Clin Rheumatol       Date:  2012-09-15       Impact factor: 2.980

4.  Use of a disease risk score to compare serious infections associated with anti-tumor necrosis factor therapy among high- versus lower-risk rheumatoid arthritis patients.

Authors:  Jeffrey R Curtis; Fenglong Xie; Lang Chen; Paul Muntner; Carlos G Grijalva; Claire Spettell; Joaquim Fernandes; Raechele M McMahan; John W Baddley; Kenneth G Saag; Timothy Beukelman; Elizabeth Delzell
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-10       Impact factor: 4.794

Review 5.  Systematic review and metaanalysis of patient self-report versus trained assessor joint counts in rheumatoid arthritis.

Authors:  Jennifer L Barton; Lindsey A Criswell; Rachel Kaiser; Yea-Hung Chen; Dean Schillinger
Journal:  J Rheumatol       Date:  2009-11-16       Impact factor: 4.666

6.  QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries.

Authors:  Tuulikki Sokka; Hannu Kautiainen; Sergio Toloza; Heidi Mäkinen; Suzan M M Verstappen; Merete Lund Hetland; Antonio Naranjo; Eva Baecklund; Gertraud Herborn; Rolf Rau; Massimiliano Cazzato; Laure Gossec; Vlado Skakic; Feride Gogus; Stanislaw Sierakowski; Barry Bresnihan; Peter Taylor; Catherine McClinton; Theodore Pincus
Journal:  Ann Rheum Dis       Date:  2007-04-05       Impact factor: 19.103

7.  Measures of rheumatoid arthritis disease activity in Australian clinical practice.

Authors:  Andrew Taylor; Hanish Bagga
Journal:  ISRN Rheumatol       Date:  2011-05-04

8.  The use of tumour necrosis factor alpha-blockers in daily routine. An Austrian consensus project.

Authors:  Burkhard F Leeb; Elke Böttcher; Hans-Peter Brezinschek; Christoph Czerwenka; Manfred Herold; Hans Hitzelhammer; Franz Mayrhofer; Rudolf Puchner; Franz Rainer; Bernhard Rintelen; Michael Schirmer; Ulrike Stuby; Hans Bröll
Journal:  Clin Rheumatol       Date:  2009-11-11       Impact factor: 2.980

9.  Usefulness of patients-reported outcomes in rheumatoid arthritis focus group.

Authors:  Jenny Amaya-Amaya; Diana Botello-Corzo; Omar-Javier Calixto; Rolando Calderón-Rojas; Aura-Maria Domínguez; Paola Cruz-Tapias; Gladis Montoya-Ortiz; Ruben-Dario Mantilla; Juan-Manuel Anaya; Adriana Rojas-Villarraga
Journal:  Arthritis       Date:  2012-09-28

10.  Tools for monitoring remission in rheumatoid arthritis: any will do, let's just pick one and start measuring.

Authors:  Yusuf Yazici; Ismail Simsek
Journal:  Arthritis Res Ther       Date:  2013-01-28       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.